| Katrina Klaus, DO | |
|
230 Worcester St, Internal Medicine, Wellesley, MA 02481-5420 | |
| (781) 431-5420 | |
| (781) 431-5465 |
| Full Name | Katrina Klaus |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 230 Worcester St, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295841427 | NPI | - | NPPES |
| 2135086 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | RT 1326 (New Hampshire) | Secondary |
| 207R00000X | Internal Medicine | 230582 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
News Archive
Wenquan Zou, MD, PhD, an expert in degenerative neurological diseases, along with his collaborators Shu G. Chen, PhD also from the Case Western Reserve University School of Medicine, Jiyan Ma, MD, PhD, from Van Andel Institute in Grand Rapids, Michigan, and Thomas Beach, MD, PhD, from Banner Sun Health Research Institute, Sun City, Arizona, have received a five-year, $3.6 million grant from the National Institutes of Health for diagnosing Parkinson's disease (PD) via an innovative skin testing approach.
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults with AF for up to 7 days.
Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to Kai-tak Wan, associate professor of engineering at Northeastern University, Boston, Mass.
Cells, which employ a process called autophagy to clean up and reuse protein debris leftover from biological processes, were the original recyclers. A team of scientists from Paul Greengard's Rockefeller University laboratory have linked a molecule that stimulates autophagy with the reduction of one of Alzheimer's disease's major hallmarks, amyloid peptide.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 8 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Wenquan Zou, MD, PhD, an expert in degenerative neurological diseases, along with his collaborators Shu G. Chen, PhD also from the Case Western Reserve University School of Medicine, Jiyan Ma, MD, PhD, from Van Andel Institute in Grand Rapids, Michigan, and Thomas Beach, MD, PhD, from Banner Sun Health Research Institute, Sun City, Arizona, have received a five-year, $3.6 million grant from the National Institutes of Health for diagnosing Parkinson's disease (PD) via an innovative skin testing approach.
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults with AF for up to 7 days.
Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to Kai-tak Wan, associate professor of engineering at Northeastern University, Boston, Mass.
Cells, which employ a process called autophagy to clean up and reuse protein debris leftover from biological processes, were the original recyclers. A team of scientists from Paul Greengard's Rockefeller University laboratory have linked a molecule that stimulates autophagy with the reduction of one of Alzheimer's disease's major hallmarks, amyloid peptide.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katrina Klaus, DO 230 Worcester St, Internal Medicine, Wellesley, MA 02481-5420 Ph: (781) 431-5420 | Katrina Klaus, DO 230 Worcester St, Internal Medicine, Wellesley, MA 02481-5420 Ph: (781) 431-5420 |
News Archive
Wenquan Zou, MD, PhD, an expert in degenerative neurological diseases, along with his collaborators Shu G. Chen, PhD also from the Case Western Reserve University School of Medicine, Jiyan Ma, MD, PhD, from Van Andel Institute in Grand Rapids, Michigan, and Thomas Beach, MD, PhD, from Banner Sun Health Research Institute, Sun City, Arizona, have received a five-year, $3.6 million grant from the National Institutes of Health for diagnosing Parkinson's disease (PD) via an innovative skin testing approach.
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a New Drug Submission (NDS) with Health Canada's Therapeutic Products Directorate (TPD) seeking Canadian approval of intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults with AF for up to 7 days.
Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to Kai-tak Wan, associate professor of engineering at Northeastern University, Boston, Mass.
Cells, which employ a process called autophagy to clean up and reuse protein debris leftover from biological processes, were the original recyclers. A team of scientists from Paul Greengard's Rockefeller University laboratory have linked a molecule that stimulates autophagy with the reduction of one of Alzheimer's disease's major hallmarks, amyloid peptide.
St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.
› Verified 8 days ago
Deborah Hadley, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 195 Worcester St, Suite 102, Wellesley, MA 02481 Phone: 617-219-1510 Fax: 617-219-1512 | |
Dr. Burt Whitney Hall, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 65 Walnut St, Suite 590, Wellesley, MA 02481 Phone: 781-237-3395 Fax: 781-237-3397 | |
Ida P Gorenburg, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Worcester St, Internal Medicine, Wellesley, MA 02481 Phone: 781-431-5220 Fax: 781-431-5526 | |
James S Sidel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Falmouth Rd, Wellesley, MA 02481 Phone: 781-237-3057 | |
David John Wenzel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Marino Center For Progressive Health, 372 Washington Street, Wellesley, MA 02481 Phone: 781-235-5200 Fax: 781-235-1103 | |
Dr. Jessica Suzanne Mosher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 William St Ste G15, Wellesley, MA 02481 Phone: 781-591-4234 Fax: 781-369-9737 | |
Charles C Pao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 Walnut Street, Suite 102, Wellesley, MA 02481 Phone: 781-943-3000 Fax: 781-943-3037 |